NEW: AngioPhase™ a ready to use, all human co-cultured in vitro angiogenesis assay kit

AngioPhase™ is a ready to use in vitro angiogenesis kit which most accurately reflects the angiogenic process in vivo. AngioPhase™ allows researchers to measure both positive and negative effectors of tubule formation.The AngioPhase™ Kit contains all of the cells and reagents  and validated controls necessary to successfully complete a 24 well angiogenesis assay. Kit controls consist of concentrated stock solutions of VEGF (2ug/ml, positive control) and Suramin (1mM, negative control).

AngioPhase KitControl wells that receive no treatment other than medium changes form extensive networks of branching tubules over a period of one to two weeks. This allows both angiogenic inhibitors and angiogenic stimulators to be assessed. The necessary medium changes are included in the kit.

The AngioPhase™ Kit is designed so that test compounds, conditioned media or tissue explants can be added to the culture at any time from the onset of vasculogenesis continuing through to advanced angiogenesis. The resulting effect on tubule formation can then be measured using Image Analysis Software, AngioSys.

The AngioPhase™ Kit is for research use only. Not for use in diagnostic procedures.

Molecules shown to be active in the AngioPhase™:

Inhibitors

Enhancers

VEGF neutralizing antibody

VEGF

VEGF antisense oligonucleotide

PIDGF

Collagen IV neutralizing antibody

BFGF

PECAM-1 neutralizing antibody

2-deoxyribose-1-P

VEGF-R antagonists

Most tumor cell conditioned media

Thrombospondin derivatives

Wound fluid

TNF alpha

Ascitic fluid from leiomyosarcoma patient

TGF b1

Ascorbic acid (biphasic response)

aVb3 integrin antagonists

 

Suramin

 

Curcumin

 

Fumagillin

 

TNP-740 (fumagillin analogue)

 

Colchicine

 

Cytochalasin B

 

Erucic acid

 

Ginsengosides

 

RGD peptide

 

Decorin

 

Endostatin

 

Thymine

 

Thalidomide and analogues

 

PAI-1 inhibitors MMP inhibitors